Home Cardiovascular risk-associated allele frequencies for 15 genes in healthy elderly French and Chinese
Article
Licensed
Unlicensed Requires Authentication

Cardiovascular risk-associated allele frequencies for 15 genes in healthy elderly French and Chinese

  • Yongjing Xia , Larry Baum , C. P. Pang , Gérard Siest and Sophie Visvikis
Published/Copyright: August 19, 2005

Abstract

In order to investigate possible ethnic differences in genetic and environmental determinants, we investigated several cardiovascular disease-associated genetic variations in successful ageing populations of France (Nancy) and China (Hong Kong). Allelic frequencies of these genetic variations were compared between healthy elderly Chinese (n=103) and French populations (n=100). A multi-locus assay was used to genotype 15 genes for 29 biallelic sites, genes implicated in lipid and homocysteine metabolism, thrombosis, leukocyte adhesion, and blood pressure regulation. For most of the candidate markers within lipid metabolism genes, the less frequent alleles were more common in the Chinese population compared with the French population, while the less frequent alleles of the majority of the other markers were detected only or more commonly in the French population. In conclusion, polymorphisms in 13 genes exhibited statistically significant differences in allelic frequencies between the two populations. Since the two populations were selected as examples of successful ageing, we could hypothesise that genetic factors that could play a role in a successful ageing process may be different between the two populations.


Corresponding author: Doctor Sophie Visvikis, INSERM U 525, Université Henri Poincaré Nancy 1, 30, rue Lionnois, BP7, 54500 Vandoeuvre-les-Nancy, France Phone: +33-3-8368-2184, Fax: +33-3-8332-1322,

References

1. Heijmans BT, Westendorp RG, Slagboom PE. Common gene variants, mortality and extreme longevity in humans. Exp Gerontol 2000; 35: 865–77. 10.1016/S0531-5565(00)00171-6Search in Google Scholar

2. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends insurvival and coronary event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Lancet 1999; 353: 1547–57. 10.1016/S0140-6736(99)04021-0Search in Google Scholar

3. Zhao D, Wu Z, Wang W, Yao L, Zhou M. The trend of incidence rate of acute coronary events from 1984 to 1997 in Beijing area Sino-MONICA Project. Chin J Cardiol 2000; 28: 14–7. Search in Google Scholar

4. Sheth T, Nair C, Nargundkar M, Anand S, Yusuf S. Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths. CMAJ 1999; 161: 132–8. Search in Google Scholar

5. Cheng S, Pallaud C, Grow MA, Scharf SJ, Erlich HA, Klitz W, et al. A multilocus genotyping assay for cardiovascular disease. Clin Chem Lab Med 1998; 36: 561–6. 10.1515/CCLM.1998.096Search in Google Scholar

6. Baum L, Chen L, Ng HK, Chan YS, Mak YT, Woo J, et al. Low density lipoprotein receptor related protein (LRP) gene exon 3 polymorphism association with Alzheimer's disease in Chinese. Neurosci Lett 1998; 247: 33–6. 10.1016/S0304-3940(98)00294-8Search in Google Scholar

7. Siest G, Visvikis S, Herbeth B, Gueguen R, Vincent-Viry M, Sass C, et al. Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: the Stanislas Cohort. Clin Chem Lab Med 1998; 36: 35–42. 10.1515/CCLM.1998.007Search in Google Scholar

8. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545–8. 10.1016/S0022-2275(20)43176-1Search in Google Scholar

9. Evans AE, Poirier O, Kee F, Lecerf L, McCrum E, Falconer T, et al. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med 1994; 87: 211–4. Search in Google Scholar

10. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor forvascular disease: a common biallelic in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111–3. 10.1038/ng0595-111Search in Google Scholar PubMed

11. Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, Visvikis S, et al. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 1999; 9: 936–49. 10.1101/gr.9.10.936Search in Google Scholar PubMed PubMed Central

12. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994; 6: 29–32. 10.1038/ng0194-29Search in Google Scholar PubMed

13. Matsushita S, Muramatsu T, Arai H, Matsui T, Higuchi S. The frequency of the methylenetetrahydrofolate reductase-gene biallelic varies with age in the normal population. Am J Hum Genet 1997; 61: 1459–60. 10.1086/301640Search in Google Scholar PubMed PubMed Central

14. Galinski D, Tysoe C, Brayne CE, Easton DF, Huppert FA, Dening TR, et al. Analysis of the apoE/apoC-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting humanlongevity. Atherosclerosis 1997; 129: 177–83. 10.1016/S0021-9150(96)06027-3Search in Google Scholar

15. Kervinen K, Savolainen MJ, Salokannel J, Hynninen A, Heikkinen J, Ehnholm C, et al. Apolipoprotein E and Bpolymorphisms – longevity factors assessed in nonagenarians. Atherosclerosis 1994; 105: 89–95. 10.1016/0021-9150(94)90011-6Search in Google Scholar

16. Bladbjerg EM, Andersen-Ranberg K, de Maat MP, Kristensen SR, Jeune B, Gram J, et al. Longevity is independent of common variations in genes associated with cardiovascular risk. Thromb Haemost 1999; 82: 1100–5. 10.1055/s-0037-1614336Search in Google Scholar

Received: 2005-1-31
Accepted: 2005-6-17
Published Online: 2005-8-19
Published in Print: 2005-8-1

©2005 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Familial hypercholesterolemia and response to statin therapy according to LDLR genetic background
  2. Detection of brain injury by fatty acid-binding proteins
  3. High-throughput scanning of breast tumor surgical specimens for low-level mutations
  4. Cardiovascular risk-associated allele frequencies for 15 genes in healthy elderly French and Chinese
  5. Soluble CD30 serum levels before and after treatment with α-interferon in patients with chronic hepatitis C
  6. Development, validation and evaluation of a homogenous one-step reverse transcriptase-initiated PCR assay with competitive internal control for the detection of hepatitis C virus RNA
  7. Counteracting adriamycin-induced oxidative stress by administration of N-acetyl cysteine and vitamin E
  8. Comparative analysis of the DNA staining efficiencies of different fluorescent dyes in preparative agarose gel electrophoresis
  9. Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma
  10. Measurement of troponin I 48h after admission as a tool to rule out impaired left ventricular function in patients with a first myocardial infarction
  11. The efficacy of cystatin C assay in the prediction of glomerular filtration rate. Is it a more reliable marker for renal failure?
  12. Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation
  13. Influence of short-term venous stasis on clinical chemistry testing
  14. Educational intervention together with an on-line quality control program achieve recommended analytical goals for bedside blood glucose monitoring in a 1200-bed university hospital
  15. The reliability of calculated laboratory results
  16. Preliminary evaluation of the performance of a new, highly sensitive commercial immunoassay for serum ferritin determination
  17. Importance of the detection method for intact dimeric human chorionic gonadotropin without interference with the free human chorionic gonadotropin β subunit for pregnancy exclusion before liver transplantation in a woman with cholangiocarcinoma
  18. Comparison of Liaison N-tact PTH (Diasorin) and N-tact PTH SP IRMA (Diasorin) in hemodialyzed patients
Downloaded on 12.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2005.137/html
Scroll to top button